210 related articles for article (PubMed ID: 26599819)
1. Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease.
Garcia AE; Kasim N; Tamboli RA; Gonzalez RS; Antoun J; Eckert EA; Marks-Shulman PA; Dunn J; Wattacheril J; Wallen T; Abumrad NN; Flynn CR
PLoS One; 2015; 10(11):e0142676. PubMed ID: 26599819
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients.
Bril F; Portillo-Sanchez P; Liu IC; Kalavalapalli S; Dayton K; Cusi K
Diabetes Care; 2018 Jan; 41(1):187-192. PubMed ID: 29133343
[TBL] [Abstract][Full Text] [Related]
3. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients.
Cassader M; Gambino R; Musso G; Depetris N; Mecca F; Cavallo-Perin P; Pacini G; Rizzetto M; Pagano G
Lipids; 2001 Oct; 36(10):1117-24. PubMed ID: 11768156
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
[TBL] [Abstract][Full Text] [Related]
5. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile.
Siddiqui MS; Fuchs M; Idowu MO; Luketic VA; Boyett S; Sargeant C; Stravitz RT; Puri P; Matherly S; Sterling RK; Contos M; Sanyal AJ
Clin Gastroenterol Hepatol; 2015 May; 13(5):1000-8.e3. PubMed ID: 25311381
[TBL] [Abstract][Full Text] [Related]
6. Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia.
Amor AJ; Pinyol M; Solà E; Catalan M; Cofán M; Herreras Z; Amigó N; Gilabert R; Sala-Vila A; Ros E; Ortega E
J Clin Lipidol; 2017; 11(2):551-561.e7. PubMed ID: 28502513
[TBL] [Abstract][Full Text] [Related]
7. Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.
Jiang ZG; Tapper EB; Connelly MA; Pimentel CF; Feldbrügge L; Kim M; Krawczyk S; Afdhal N; Robson SC; Herman MA; Otvos JD; Mukamal KJ; Lai M
Liver Int; 2016 Aug; 36(8):1213-20. PubMed ID: 26815314
[TBL] [Abstract][Full Text] [Related]
8. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
Garvey WT; Kwon S; Zheng D; Shaughnessy S; Wallace P; Hutto A; Pugh K; Jenkins AJ; Klein RL; Liao Y
Diabetes; 2003 Feb; 52(2):453-62. PubMed ID: 12540621
[TBL] [Abstract][Full Text] [Related]
9. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
[TBL] [Abstract][Full Text] [Related]
10. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
Barb D; Bril F; Kalavalapalli S; Cusi K
J Clin Endocrinol Metab; 2019 Aug; 104(8):3327-3336. PubMed ID: 30848827
[TBL] [Abstract][Full Text] [Related]
11. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
Männistö VT; Simonen M; Soininen P; Tiainen M; Kangas AJ; Kaminska D; Venesmaa S; Käkelä P; Kärjä V; Gylling H; Ala-Korpela M; Pihlajamäki J
J Lipid Res; 2014 Dec; 55(12):2676-84. PubMed ID: 25344588
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.
Lomonaco R; Bril F; Portillo-Sanchez P; Ortiz-Lopez C; Orsak B; Biernacki D; Lo M; Suman A; Weber MH; Cusi K
Diabetes Care; 2016 Apr; 39(4):632-8. PubMed ID: 26861926
[TBL] [Abstract][Full Text] [Related]
14. The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitis.
Poljo A; Kopf S; Sulaj A; Roessler S; Albrecht T; Goeppert B; Bojko S; Müller-Stich BP; Billeter AT
Surg Obes Relat Dis; 2023 Dec; 19(12):1421-1434. PubMed ID: 37666725
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter?
Phillips CM; Perry IJ
Atherosclerosis; 2015 Oct; 242(2):399-406. PubMed ID: 26277632
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.
Musso G; Cassader M; De Michieli F; Rosina F; Orlandi F; Gambino R
Hepatology; 2012 Sep; 56(3):933-42. PubMed ID: 22684858
[TBL] [Abstract][Full Text] [Related]
17. A study of the metabolism of apolipoprotein B100 in relation to insulin resistance in African American males.
Sumner AE; Falkner B; Diffenderfer MR; Barrett PH; Marsh JB
Proc Soc Exp Biol Med; 1999 Sep; 221(4):352-60. PubMed ID: 10460697
[TBL] [Abstract][Full Text] [Related]
18. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein subpopulation distributions in lean, obese, and type 2 diabetic women: a comparison of African and white Americans.
MacLean PS; Bower JF; Vadlamudi S; Green T; Barakat HA
Obes Res; 2000 Jan; 8(1):62-70. PubMed ID: 10678260
[TBL] [Abstract][Full Text] [Related]
20. Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis.
Lomonaco R; Ortiz-Lopez C; Orsak B; Finch J; Webb A; Bril F; Louden C; Tio F; Cusi K
Hepatology; 2011 Sep; 54(3):837-45. PubMed ID: 21674556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]